Miracle Mile Advisors, LLC Anavex Life Sciences Corp. Transaction History

Miracle Mile Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$7.66 - $9.5 $118,668 - $147,174	15,492 New	15,492 $125,000
Q4 2022 Jan 20, 2023	BUY	$7.65 - $14.43 $80,684 - $152,193	10,547 New	10,547 $0
Q4 2021 Jan 18, 2022	SELL	$16.88 - $23.31 $1.04 Million - $1.44 Million	-61,656 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$16.82 - $25.75 $1.04 Million - $1.59 Million	61,656 New	61,656 $1.11 Million

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Miracle Mile Advisors, LLC with notifications on news.